minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - STU 2.1
minimal Common Oncology Data Elements (mCODE) Implementation Guide
2.1.0 - STU 2.1
This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.1.0: STU 2) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions 
| Official URL: http://hl7.org/fhir/us/mcode/ValueSet/elixhauser-neurological-movement-disorder-vs | Version: 2.1.0 | |||
| Active as of 2023-03-21 | Computable Name: ElixhauserNeurologicalMovementDisorderVS | |||
Elixhauser Comorbid Condition Value Set for Neurological Movement Disorders. ICD-10 codes are drawn from https://www.hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comorbidity_icd10.jsp, version 2021.1
References
http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| G08 | Intracranial and intraspinal phlebitis and thrombophlebitis |
| G10 | Huntington's disease |
| G11.0 | Congenital nonprogressive ataxia |
| G11.1 | Early-onset cerebellar ataxia |
| G11.10 | Early-onset cerebellar ataxia, unspecified |
| G11.11 | Friedreich ataxia |
| G11.19 | Other early-onset cerebellar ataxia |
| G11.2 | Late-onset cerebellar ataxia |
| G11.3 | Cerebellar ataxia with defective DNA repair |
| G11.4 | Hereditary spastic paraplegia |
| G11.8 | Other hereditary ataxias |
| G11.9 | Hereditary ataxia, unspecified |
| G12.0 | Infantile spinal muscular atrophy, type I [Werdnig-Hoffman] |
| G12.1 | Other inherited spinal muscular atrophy |
| G12.20 | Motor neuron disease, unspecified |
| G12.21 | Amyotrophic lateral sclerosis |
| G12.22 | Progressive bulbar palsy |
| G12.23 | Primary lateral sclerosis |
| G12.24 | Familial motor neuron disease |
| G12.25 | Progressive spinal muscle atrophy |
| G12.29 | Other motor neuron disease |
| G12.8 | Other spinal muscular atrophies and related syndromes |
| G12.9 | Spinal muscular atrophy, unspecified |
| G13.0 | Paraneoplastic neuromyopathy and neuropathy |
| G13.1 | Other systemic atrophy primarily affecting central nervous system in neoplastic disease |
| G13.2 | Systemic atrophy primarily affecting the cnsl in myxedema |
| G13.8 | Systemic atrophy aff cnsl in oth diseases classd elswhr |
| G20 | Parkinson's disease |
| G21.0 | Malignant neuroleptic syndrome |
| G21.11 | Neuroleptic induced parkinsonism |
| G21.19 | Other drug induced secondary parkinsonism |
| G21.2 | Secondary parkinsonism due to other external agents |
| G21.3 | Postencephalitic parkinsonism |
| G21.4 | Vascular parkinsonism |
| G21.8 | Other secondary parkinsonism |
| G21.9 | Secondary parkinsonism, unspecified |
| G23.0 | Hallervorden-Spatz disease |
| G23.1 | Progressive supranuclear ophthalmoplegia |
| G23.2 | Striatonigral degeneration |
| G23.8 | Other specified degenerative diseases of basal ganglia |
| G23.9 | Degenerative disease of basal ganglia, unspecified |
| G24.09 | Other drug induced dystonia |
| G24.1 | Genomic torsion dystonia |
| G24.2 | Idiopathic nonfamilial dystonia |
| G24.8 | Other dystonia |
| G25.4 | Drug-induced chorea |
| G25.5 | Other chorea |
| G25.70 | Drug induced movement disorder, unspecified |
| G25.71 | Drug induced akathisia |
| G25.79 | Other drug induced movement disorders |
| G25.81 | Restless legs syndrome |
| G25.82 | Stiff-man syndrome |
| G25.83 | Benign shuddering attacks |
| G25.89 | Other specified extrapyramidal and movement disorders |
| G25.9 | Extrapyramidal and movement disorder, unspecified |
| G26 | Extrapyramidal and movement disord in diseases classd elswhr |
| G32.0 | Subac comb degeneration of spinal cord in dis classd elswhr |
| G32.81 | Cerebellar ataxia in diseases classified elsewhere |
| G32.89 | Oth degeneratv disord of nervous sys in dis classd elswhr |
| G80.3 | Athetoid cerebral palsy |
This value set contains 60 concepts
Expansion based on http://hl7.org/fhir/sid/icd-10-cm version 2021
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2022+ HL7 International Clinical Interoperability Council. Package hl7.fhir.us.mcode#2.1.0 based on FHIR 4.0.1. Generated 2023-03-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change